Regeneron Pharmaceuticals, Inc.

WEDGE CAPITAL MANAGEMENT L L P/NC REGN

Report date

6/30/2026

Quarter

2026 Q2

Filed

7/10/2026

Shares

47,775

Value ($000)

29,790

Weight

0.5%

2025 Q3 - 2026 Q2 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	7/10/2026	29,790	0.5%	47,775	6/30/2026
2026 Q1	4/13/2026	30,683	0.6%	39,712	3/31/2026
2025 Q4	1/14/2026	31,880	0.6%	41,302	12/31/2025
2025 Q3	10/10/2025	25,412	0.4%	45,195	9/30/2025